Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine.

Hlaca, Nika; Zagar, Tina; Kastelan, Marija; Peternel, Sandra; Brajac, Ines; Dujmovic-Hasanbegovic, Katarina; Prpic-Massari, Larisa

Hlaca, Nika; Zagar, Tina; Kastelan, Marija; Peternel, Sandra; Brajac, Ines; Dujmovic-Hasanbegovic, Katarina; Prpic-Massari, Larisa.

Afiliación

Hlaca N; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Zagar T; Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Kastelan M; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Peternel S; Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Brajac I; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.
Dujmovic-Hasanbegovic K; Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Prpic-Massari L; Department of Dermatovenerology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.

Dermatol Ther ; 35(11): e15791, 2022 11.

Article en En | MEDLINE | ID: mdl-36029037

Asunto(s)

COVID-19; Pitiriasis Rubra Pilaris; Humanos; Vacunas contra la COVID-19/efectos adversos; ARN Mensajero; COVID-19/prevención & control

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pitiriasis Rubra Pilaris / COVID-19 Límite: Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Croacia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google